Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-23-005910

EVP and COO sold 424 shares at $11.78 ($4,995)

  • EVP and COO acquired 962 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Wolff Stefani · EVP and COO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-30 Exercise or conversion : show line 1 in the form +962 4,364 D
2023-01-30 Sale : show line 2 in the form −424 $11.78 $4,995 3,940 D
Open-market sales · 424 sh · avg $11.78 · $4,995

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −962 11,544 D
Loading xslF345X03/doc4.xml…